Clinical Scorecard: A Comprehensive Review of EEG Biomarkers for Depression, Anxiety, and Bipolar Disorder: Insights into Explainable Artificial Intelligence (XAI) Trends

At a Glance

Key Highlights

• EEG combined with deep learning enables detection and classification of psychiatric disorders through hierarchical data representations.
• Explainable AI (XAI) techniques such as SHAP and LIME enhance transparency and clinical trust by revealing EEG feature importance.
• XAI integration addresses the 'black box' limitation of deep learning, supporting personalized care and targeted interventions.

Guideline-Based Recommendations

Diagnosis

• Utilize EEG biomarkers analyzed with advanced ML algorithms to assist in identifying depression, anxiety, and bipolar disorder.
• Incorporate XAI methods to interpret model predictions and improve diagnostic transparency.

Management

• Apply EEG-based ML models to monitor disease progression and predict treatment outcomes.
• Use XAI insights to guide personalized intervention strategies.

Monitoring & Follow-up

• Leverage EEG signal changes and ML model outputs for ongoing assessment of psychiatric conditions.
• Employ XAI to understand individual-level prediction variations and subgroup differences.

Risks

• Be aware of computational costs associated with XAI techniques on large EEG datasets.
• Recognize the current lack of standardized evaluation frameworks for clinical utility of XAI explanations.
• Consider ethical and regulatory requirements for transparency and fairness in AI applications.

Patient & Prescribing Data

Patients diagnosed or at risk for depression, anxiety, and bipolar disorder undergoing EEG evaluation

EEG-based ML models enhanced with XAI can inform risk stratification, treatment response prediction, and personalized care planning

Clinical Best Practices

• Integrate explainable AI approaches to improve clinician trust and facilitate adoption of EEG-based diagnostic tools.
• Prioritize feature selection and preprocessing strategies to optimize ML model performance in psychiatric EEG analysis.
• Develop computationally efficient XAI methods suitable for large-scale EEG datasets to maintain clinical feasibility.
• Conduct clinically validated studies to establish the impact of XAI-enhanced EEG analysis on diagnostic accuracy and treatment outcomes.
• Address ethical and regulatory considerations by ensuring AI transparency, fairness, and interpretability in psychiatric care.

References

• EEG in psychiatric disorders overview
• Deep learning for EEG classification
• Explainable AI methods in healthcare
• SHAP and LIME for model interpretability
• Ethical considerations in AI transparency